Exact Mass: 487.2238
Exact Mass Matches: 487.2238
Found 500 metabolites which its exact mass value is equals to given mass value 487.2238
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Myxothiazol
A 2,4-bi-1,3-thiazole substituted at the 4-position with a (1E,3S,4R,5E)-7-amino-3,5-dimethoxy-4-methyl-7-oxohepta-1,5-dien-1-yl] group and at the 2-position with a (2S,3E,5E)-7-methylocta-3,5-dien-2-yl group. It is an inhibitor of coenzyme Q - cytochrome c reductase. D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors
Ac-Ser-Asp-Lys-Pro-OH
Ac-Ser-Asp-Lys-Pro-OH, also known as Ac-ser-asp-lys-pro or AcSDKP-NH2, is classified as a member of the Oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Ac-Ser-Asp-Lys-Pro-OH is considered to be practically insoluble (in water) and acidic D020011 - Protective Agents > D011837 - Radiation-Protective Agents D006133 - Growth Substances > D006131 - Growth Inhibitors C26170 - Protective Agent
Acetyl-Ser-Asp-Lys-Pro
D020011 - Protective Agents > D011837 - Radiation-Protective Agents D006133 - Growth Substances > D006131 - Growth Inhibitors
Pemigatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor
Sarecycline
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic D003879 - Dermatologic Agents
4-[[4-hydroxy-2-(2-methylpropyl)-1-oxo-3,3a-dihydro-2H-imidazo[1,2-a]indol-4-yl]methyl]-1-methyl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione
Ala Asp Pro Trp
Ala Asp Trp Pro
Ala Phe His Asn
Ala Phe Asn His
Ala His Phe Asn
Ala His Asn Phe
Ala Asn Phe His
Ala Asn His Phe
Ala Asn Gln Arg
Ala Asn Arg Gln
Ala Pro Asp Trp
Ala Pro Trp Asp
Ala Gln Asn Arg
Ala Gln Arg Asn
Ala Arg Asn Gln
Ala Arg Gln Asn
Ala Trp Asp Pro
Ala Trp Pro Asp
Cys His Lys Thr
Cys His Thr Lys
Cys Lys His Thr
Cys Lys Thr His
Cys Thr His Lys
Cys Thr Lys His
Asp Ala Pro Trp
Asp Ala Trp Pro
Asp Glu Lys Pro
Asp Glu Pro Lys
Asp Lys Glu Pro
Asp Lys Pro Glu
Asp Pro Ala Trp
Asp Pro Glu Lys
Asp Pro Lys Glu
Asp Pro Arg Thr
Asp Pro Thr Arg
Asp Pro Trp Ala
Asp Arg Pro Thr
Asp Arg Thr Pro
Asp Thr Pro Arg
Asp Thr Arg Pro
Asp Trp Ala Pro
Asp Trp Pro Ala
Glu Asp Lys Pro
Glu Asp Pro Lys
Glu Gly Pro Trp
Glu Gly Trp Pro
Glu Lys Asp Pro
Glu Lys Pro Asp
Glu Pro Asp Lys
Glu Pro Gly Trp
Glu Pro Lys Asp
Glu Pro Arg Ser
Glu Pro Ser Arg
Glu Pro Trp Gly
Glu Arg Pro Ser
Glu Arg Ser Pro
Glu Ser Pro Arg
Glu Ser Arg Pro
Glu Trp Gly Pro
Glu Trp Pro Gly
Phe Ala His Asn
Phe Ala Asn His
Phe Gly His Gln
Phe Gly Gln His
Phe His Ala Asn
Phe His Gly Gln
Phe His Asn Ala
Phe His Gln Gly
Phe Asn Ala His
Phe Asn His Ala
Phe Pro Pro Gln
Phe Pro Gln Pro
Phe Gln Gly His
Phe Gln His Gly
Phe Gln Pro Pro
Gly Glu Pro Trp
Gly Glu Trp Pro
Gly Phe His Gln
Gly Phe Gln His
Gly His Phe Gln
Gly His Gln Phe
Gly Pro Glu Trp
Gly Pro Trp Glu
Gly Gln Phe His
Gly Gln His Phe
Gly Gln Gln Arg
Gly Gln Arg Gln
Gly Arg Gln Gln
Gly Trp Glu Pro
Gly Trp Pro Glu
His Ala Phe Asn
His Ala Asn Phe
His Cys Lys Thr
His Cys Thr Lys
His Phe Ala Asn
His Phe Gly Gln
His Phe Asn Ala
His Phe Gln Gly
His Gly Phe Gln
His Gly Gln Phe
His Lys Cys Thr
His Lys Thr Cys
His Asn Ala Phe
His Asn Phe Ala
His Gln Phe Gly
His Gln Gly Phe
His Thr Cys Lys
His Thr Lys Cys
Ile Met Pro Gln
Ile Met Gln Pro
Ile Asn Asn Gln
Ile Asn Gln Asn
Ile Pro Met Gln
Ile Pro Gln Met
Ile Gln Met Pro
Ile Gln Asn Asn
Ile Gln Pro Met
Lys Cys His Thr
Lys Cys Thr His
Lys Asp Glu Pro
Lys Asp Pro Glu
Lys Glu Asp Pro
Lys Glu Pro Asp
Lys His Cys Thr
Lys His Thr Cys
Lys Pro Asp Glu
Lys Pro Glu Asp
Lys Thr Cys His
Lys Thr His Cys
Leu Met Pro Gln
Leu Met Gln Pro
Leu Asn Asn Gln
Leu Asn Gln Asn
Leu Pro Met Gln
Leu Pro Gln Met
Leu Gln Met Pro
Leu Gln Asn Asn
Leu Gln Pro Met
Met Ile Pro Gln
Met Ile Gln Pro
Met Leu Pro Gln
Met Leu Gln Pro
Met Pro Ile Gln
Met Pro Leu Gln
Met Pro Gln Ile
Met Pro Gln Leu
Met Gln Ile Pro
Met Gln Leu Pro
Met Gln Pro Ile
Met Gln Pro Leu
Asn Ala Phe His
Asn Ala His Phe
Asn Ala Gln Arg
Asn Ala Arg Gln
Asn Phe Ala His
Asn Phe His Ala
Asn His Ala Phe
Asn His Phe Ala
Asn Ile Asn Gln
Asn Ile Gln Asn
Asn Leu Asn Gln
Asn Leu Gln Asn
Asn Asn Ile Gln
Asn Asn Leu Gln
Asn Asn Gln Ile
Asn Asn Gln Leu
Asn Gln Ala Arg
Asn Gln Ile Asn
Asn Gln Leu Asn
Asn Gln Asn Ile
Asn Gln Asn Leu
Asn Gln Gln Val
Asn Gln Arg Ala
Asn Gln Val Gln
Asn Arg Ala Gln
Asn Arg Gln Ala
Asn Val Gln Gln
Pro Ala Asp Trp
Pro Ala Trp Asp
Pro Asp Ala Trp
Pro Asp Glu Lys
Pro Asp Lys Glu
Pro Asp Arg Thr
Pro Asp Thr Arg
Pro Asp Trp Ala
Pro Glu Asp Lys
Pro Glu Gly Trp
Pro Glu Lys Asp
Pro Glu Arg Ser
Pro Glu Ser Arg
Pro Glu Trp Gly
Pro Phe Pro Gln
Pro Phe Gln Pro
Pro Gly Glu Trp
Pro Gly Trp Glu
Pro Ile Met Gln
Pro Ile Gln Met
Pro Lys Asp Glu
Pro Lys Glu Asp
Pro Leu Met Gln
Pro Leu Gln Met
Pro Met Ile Gln
Pro Met Leu Gln
Pro Met Gln Ile
Pro Met Gln Leu
Pro Pro Phe Gln
Pro Pro Gln Phe
Pro Gln Phe Pro
Pro Gln Ile Met
Pro Gln Leu Met
Pro Gln Met Ile
Pro Gln Met Leu
Pro Gln Pro Phe
Pro Arg Asp Thr
Pro Arg Glu Ser
Pro Arg Ser Glu
Pro Arg Thr Asp
Pro Ser Glu Arg
Pro Ser Arg Glu
Pro Ser Val Trp
Pro Ser Trp Val
Pro Thr Asp Arg
Pro Thr Arg Asp
Pro Val Ser Trp
Pro Val Trp Ser
Pro Trp Ala Asp
Pro Trp Asp Ala
Pro Trp Glu Gly
Pro Trp Gly Glu
Pro Trp Ser Val
Pro Trp Val Ser
Gln Ala Asn Arg
Gln Ala Arg Asn
Gln Phe Gly His
Gln Phe His Gly
Gln Phe Pro Pro
Gln Gly Phe His
Gln Gly His Phe
Gln Gly Gln Arg
Gln Gly Arg Gln
Gln His Phe Gly
Gln His Gly Phe
Gln Ile Met Pro
Gln Ile Asn Asn
Gln Ile Pro Met
Gln Leu Met Pro
Gln Leu Asn Asn
Gln Leu Pro Met
Gln Met Ile Pro
Gln Met Leu Pro
Gln Met Pro Ile
Gln Met Pro Leu
Gln Asn Ala Arg
Gln Asn Ile Asn
Gln Asn Leu Asn
Gln Asn Asn Ile
Gln Asn Asn Leu
Gln Asn Gln Val
Gln Asn Arg Ala
Gln Asn Val Gln
Gln Pro Phe Pro
Gln Pro Ile Met
Gln Pro Leu Met
Gln Pro Met Ile
Gln Pro Met Leu
Gln Pro Pro Phe
Gln Gln Gly Arg
Gln Gln Asn Val
Gln Gln Arg Gly
Gln Gln Val Asn
Gln Arg Ala Asn
Gln Arg Gly Gln
Gln Arg Asn Ala
Gln Arg Gln Gly
Gln Val Asn Gln
Gln Val Gln Asn
Arg Ala Asn Gln
Arg Ala Gln Asn
Arg Asp Pro Thr
Arg Asp Thr Pro
Arg Glu Pro Ser
Arg Glu Ser Pro
Arg Gly Gln Gln
Arg Asn Ala Gln
Arg Asn Gln Ala
Arg Pro Asp Thr
Arg Pro Glu Ser
Arg Pro Ser Glu
Arg Pro Thr Asp
Arg Gln Ala Asn
Arg Gln Gly Gln
Arg Gln Asn Ala
Arg Gln Gln Gly
Arg Ser Glu Pro
Arg Ser Pro Glu
Arg Thr Asp Pro
Arg Thr Pro Asp
Ser Glu Pro Arg
Ser Glu Arg Pro
Ser Pro Glu Arg
Ser Pro Arg Glu
Ser Pro Val Trp
Ser Pro Trp Val
Ser Arg Glu Pro
Ser Arg Pro Glu
Ser Val Pro Trp
Ser Val Trp Pro
Ser Trp Pro Val
Ser Trp Val Pro
Thr Cys His Lys
Thr Cys Lys His
Thr Asp Pro Arg
Thr Asp Arg Pro
Thr His Cys Lys
Thr His Lys Cys
Thr Lys Cys His
Thr Lys His Cys
Thr Pro Asp Arg
Thr Pro Arg Asp
Thr Arg Asp Pro
Thr Arg Pro Asp
Val Asn Gln Gln
Val Pro Ser Trp
Val Pro Trp Ser
Val Gln Asn Gln
Val Gln Gln Asn
Val Ser Pro Trp
Val Ser Trp Pro
Val Trp Pro Ser
Val Trp Ser Pro
Trp Ala Asp Pro
Trp Ala Pro Asp
Trp Asp Ala Pro
Trp Asp Pro Ala
Trp Glu Gly Pro
Trp Glu Pro Gly
Trp Gly Glu Pro
Trp Gly Pro Glu
Trp Pro Ala Asp
Trp Pro Asp Ala
Trp Pro Glu Gly
Trp Pro Gly Glu
Trp Pro Ser Val
Trp Pro Val Ser
Trp Ser Pro Val
Trp Ser Val Pro
Trp Val Pro Ser
Trp Val Ser Pro
(1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-{[(1-{[(2-methyl-2-prop anyl)oxy]carbonyl}-4-piperidinyl)carbonyl]amino}-1H-indol-2-yl)bo ronic acid
3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylpyrazolo[3,4-b]pyridine
Avitinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Valemetostat
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor
Zotatifin
C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Sarecycline
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic D003879 - Dermatologic Agents
Pemigatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor
(+)-Myxothiazol
D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors
N-[(E)-2-[5-(1,3-benzothiazol-2-yl)-3-ethyl-1-phenylbenzimidazol-3-ium-2-yl]ethenyl]-N-methylaniline
sodium(E)-((1R,4aS,4bS,8aS,10aS)-4b,8,8,10a-tetramethyl-1-(2-(2-oxo-2,5-dihydro-1H-pyrrol-3-yl)ethyl)decahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
A natural product found in Coscinoderma species.
(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid
1-(1-tert-butyl-5-tetrazolyl)-N-[(4-fluorophenyl)methyl]-N-(2-furanylmethyl)-1-[4-(trifluoromethyl)phenyl]methanamine
(2S)-2-[[[4-[[4-[[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]methyl]anilino]-oxomethyl]-1H-imidazol-5-yl]-oxomethyl]amino]propanoic acid tert-butyl ester
2-[(1S,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
2-[(1S,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
(6S,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
(2S)-2-[(4R,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(1R,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
(1R,9S,10S,11S)-12-(cyclobutanecarbonyl)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-12-benzoyl-5-(cyclopenten-1-yl)-N-cyclopentyl-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
(2R)-2-[(4S,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)carbamoylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
(2R)-2-[(4R,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
3,3,3-trifluoro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(1S,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
2-[(1R,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
(1S,9R,10R,11R)-12-(cyclobutanecarbonyl)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-12-benzoyl-5-(cyclopenten-1-yl)-N-cyclopentyl-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(1R)-1-(3-fluorophenyl)sulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol
[(1S)-1-(3-fluorophenyl)sulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol
1-[(1R)-1-benzoyl-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-2-cyclopropylethanone
(6R,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
1-Benzyl-5-(3,4-dimethoxyphenyl)-8,8-dimethyl-5,5a,7,9-tetrahydropyrimido[4,5-b]quinoline-2,4,6-trione
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
goralatide
D020011 - Protective Agents > D011837 - Radiation-Protective Agents D006133 - Growth Substances > D006131 - Growth Inhibitors C26170 - Protective Agent
LP44 (hydrochloride)
LP44 (hydrochloride) is a selective 5-HT7 agonist with Ki of 0.22 nM. LP44 (hydrochloride) induces hypothermic effect in a dose-dependent manner by intracerebroventricular injection. LP44 (hydrochloride) not causes considerable hypothermic response by intraperitoneal administration[1].